Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels.

Hayashi Y, Nemoto-Sasaki Y, Matsumoto N, Hama K, Tanikawa T, Oka S, Saeki T, Kumasaka T, Koizumi T, Arai S, Wada I, Yokoyama K, Sugiura T, Yamashita A.

J Biol Chem. 2018 Nov 9;293(45):17505-17522. doi: 10.1074/jbc.RA118.002048. Epub 2018 Sep 21.

PMID:
30242129
2.

Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.

Yamashita A, Hayashi Y, Matsumoto N, Nemoto-Sasaki Y, Koizumi T, Inagaki Y, Oka S, Tanikawa T, Sugiura T.

Biology (Basel). 2017 Mar 30;6(2). pii: E23. doi: 10.3390/biology6020023. Review.

3.

Carboxyl-terminal Tail-mediated Homodimerizations of Sphingomyelin Synthases Are Responsible for Efficient Export from the Endoplasmic Reticulum.

Hayashi Y, Nemoto-Sasaki Y, Matsumoto N, Tanikawa T, Oka S, Tanaka Y, Arai S, Wada I, Sugiura T, Yamashita A.

J Biol Chem. 2017 Jan 20;292(3):1122-1141. doi: 10.1074/jbc.M116.746602. Epub 2016 Dec 7.

4.

Glycerophosphate/Acylglycerophosphate acyltransferases.

Yamashita A, Hayashi Y, Matsumoto N, Nemoto-Sasaki Y, Oka S, Tanikawa T, Sugiura T.

Biology (Basel). 2014 Nov 19;3(4):801-30. doi: 10.3390/biology3040801. Review.

5.

Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion.

Hayashi Y, Nemoto-Sasaki Y, Tanikawa T, Oka S, Tsuchiya K, Zama K, Mitsutake S, Sugiura T, Yamashita A.

J Biol Chem. 2014 Oct 31;289(44):30842-56. doi: 10.1074/jbc.M114.574285. Epub 2014 Sep 17.

6.

Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms.

Yamashita A, Hayashi Y, Nemoto-Sasaki Y, Ito M, Oka S, Tanikawa T, Waku K, Sugiura T.

Prog Lipid Res. 2014 Jan;53:18-81. doi: 10.1016/j.plipres.2013.10.001. Epub 2013 Oct 11. Review.

PMID:
24125941
7.

The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.

Yamashita A, Oka S, Tanikawa T, Hayashi Y, Nemoto-Sasaki Y, Sugiura T.

Prostaglandins Other Lipid Mediat. 2013 Dec;107:103-16. doi: 10.1016/j.prostaglandins.2013.05.004. Epub 2013 May 25. Review.

PMID:
23714700
8.

Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation.

Mimura T, Oka S, Koshimoto H, Ueda Y, Watanabe Y, Sugiura T.

Int Arch Allergy Immunol. 2012;159(2):149-56. doi: 10.1159/000336167. Epub 2012 May 31.

PMID:
22652530
9.

The cannabinoid receptor-2 is involved in allergic inflammation.

Mimura T, Ueda Y, Watanabe Y, Sugiura T.

Life Sci. 2012 Jun 6;90(21-22):862-6. doi: 10.1016/j.lfs.2012.04.005. Epub 2012 Apr 14.

PMID:
22525379
10.

[Lysophosphatidylinositol as a novel lipid mediator].

Sugiura T, Yamashita A, Oka S.

Seikagaku. 2011 Jun;83(6):525-35. Review. Japanese. No abstract available.

PMID:
21800683
11.

GPR35 is a novel lysophosphatidic acid receptor.

Oka S, Ota R, Shima M, Yamashita A, Sugiura T.

Biochem Biophys Res Commun. 2010 Apr 30;395(2):232-7. doi: 10.1016/j.bbrc.2010.03.169. Epub 2010 Mar 31.

PMID:
20361937
12.

Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): Possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1.

Yamashita A, Kumazawa T, Koga H, Suzuki N, Oka S, Sugiura T.

Biochim Biophys Acta. 2010 Jul;1801(7):711-20. doi: 10.1016/j.bbalip.2010.03.012. Epub 2010 Mar 30.

PMID:
20359546
13.

Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.

Oka S, Kimura S, Toshida T, Ota R, Yamashita A, Sugiura T.

J Biochem. 2010 May;147(5):671-8. doi: 10.1093/jb/mvp208. Epub 2010 Jan 4.

PMID:
20051382
14.

Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment.

Kittaka A, Hara H, Takano M, Sawada D, Arai MA, Takagi K, Chida T, Harada Y, Saito H, Takenouchi K, Ishizuka S, Hayashi K, Ikushiro S, Sakaki T, Sugiura T, Chen TC.

Anticancer Res. 2009 Sep;29(9):3563-9.

15.

Subcellular localization and lysophospholipase/transacylation activities of human group IVC phospholipase A2 (cPLA2gamma).

Yamashita A, Tanaka K, Kamata R, Kumazawa T, Suzuki N, Koga H, Waku K, Sugiura T.

Biochim Biophys Acta. 2009 Oct;1791(10):1011-22. doi: 10.1016/j.bbalip.2009.05.008. Epub 2009 Jun 6.

PMID:
19501189
16.

Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.

Sugiura T.

Biofactors. 2009 Jan-Feb;35(1):88-97. doi: 10.1002/biof.18. Review.

PMID:
19319851
17.

2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.

Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T.

J Biochem. 2009 Jan;145(1):13-20. doi: 10.1093/jb/mvn136. Epub 2008 Oct 9.

PMID:
18845565
18.

The 2alpha-(3-hydroxypropyl) group as an active motif in vitamin D3 analogues as agonists of the mutant vitamin D receptor (Arg274Leu).

Honzawa S, Yamamoto Y, Yamashita A, Sugiura T, Kurihara M, Arai MA, Kato S, Kittaka A.

Bioorg Med Chem. 2008 Mar 15;16(6):3002-24. doi: 10.1016/j.bmc.2007.12.039. Epub 2008 Jan 14.

PMID:
18248997
19.

(2S,2'R)-analogue of LG190178 is a major active isomer.

Hakamata W, Sato Y, Okuda H, Honzawa S, Saito N, Kishimoto S, Yamashita A, Sugiura T, Kittaka A, Kurihara M.

Bioorg Med Chem Lett. 2008 Jan 1;18(1):120-3. Epub 2007 Nov 5.

PMID:
18054230
20.

Identification of GPR55 as a lysophosphatidylinositol receptor.

Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T.

Biochem Biophys Res Commun. 2007 Nov 3;362(4):928-34. Epub 2007 Aug 24.

PMID:
17765871

Supplemental Content

Loading ...
Support Center